Source: International Congress 2017 – Metabolism in respiratory diseases: time for a rethink



Rating:

Share or cite this content

Citations should be made in the following way:
O. Barash (Israel). Metabolic reprogramming and the risk of lung cancer. International Congress 2017 – Metabolism in respiratory diseases: time for a rethink

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for early mortality in lung cancer Source: Annual Congress 2012 - Epidemiology and care research of lung cancer Year: 2012 Risk factors for lung cancer in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017 Risk factors for lung cancer worldwide Source: Eur Respir J 2016; 48: 889-902 Year: 2016 Epigenetics and lung cancer Source: Annual Congress 2006 - Epigenetics and respiratory disease Year: 2006 Risk factors for vascular events during lung cancer chemotherapy Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010 Epigenetics and lung cancer Source: Annual Congress 2008 - Deadly networks: disease-causing protein and DNA modifications Year: 2008 Prior lung disease and risk of lung cancer in women Source: Eur Respir J 2005; 26: Suppl. 49, 598s Year: 2005 Comorbidities in lung cancer progression Source: International Congress 2017 – ME12 Comorbidities in lung cancer progression Year: 2017 Dysplasia and aberrant methylation profiles in risk and lung cancer patients Source: Eur Respir J 2005; 26: Suppl. 49, 458s Year: 2005 Exploration of the evidence of cancer stem cells in lung cancer Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Interstital lung disease rates and risk factors in a UK lung cancer screening trial Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Evaluation of causes and characteristics of lung cancer mortality Source: Eur Respir J 2005; 26: Suppl. 49, 321s Year: 2005 Markers of angiogenesis in serum are correlating with disease progress in lung cancer Source: Annual Congress 2006 - Prognostic factors in lung cancer Year: 2006 Genetic predisposition to nonsmall-cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 1s Year: 2001 Association of the PDCD5 locus with lung cancer risk and prognosis in smokers Source: Annual Congress 2007 - Novel genetic markers in pathology Year: 2007 Lung cancer and associated diseases Source: Eur Respir J 2001; 18: Suppl. 33, 66s Year: 2001